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Purpose or Objective: Post-mastectomy radiation therapy 
(RT) is a prophylactic adjuvant treatment for high risk 
patients with breast cancer. Mammary prostheses or 
expanders often do not tolerate RT causing a reduction of 
aesthetic profile and, even more, an exposure to clinical risks 
or new surgery. In this retrospective study clinical and 
aesthetic results were quantified in patients who did or did 
not undergo adjuvant RT after reconstruction for breast 
cancer 
 
Material and Methods: Patients who underwent mastectomy 
with immediate mammary reconstruction for breast cancer 
and who had a follow-up (FUP) period of at least six months 
were selected for this retrospective study. Two subgroups 
were defined between irradiated or not patients. All the 
patients were submitted to the scheduled surgical and 
oncoplastic FUP and the irradiated ones underwent also a RT 
FUP program. For both groups local infection rate (IR), 
lipofilling rate (LR), reconstruction with DIEP flap rate 
(DIEPR), local control (LC) and distant failure rate (DFR) were 
analyzed. All chi square tests were performed on MedCalc. 
For the irradiated patients acute and late toxicities were also 
registered according to CTCAE v4.0 scale 
 
Results: From January 2012 to April 2015, 152 patients 
underwent mastectomy with prostheses or expanders. Out of 
them, 76 pts were candidates to standard adjuvant RT for 
high risk factors, according to NCCN guidelines. Mean age was 
48 years (range 32-74). Median FUP was 28 months (range 6-
44). IR, LR, DIEPR are reported in Table 1. 21% of not 
irradiated pts underwent second surgery to replace the 
expander with the prostheses. LC was equal in both group. 
High risk pts had higher DFR than low-medium risk ones 
(5.26% vs 0 with p<0.05). Regarding irradiated patients acute 
skin toxicities G0, G1, G2 and G3 were 38%, 40%, 12% and 
9.8% respectively. We reported late skin toxicities rates of: 
G0 20%, G1 28%, G2 42% and G3 10% (Figure 1). 
 
 Adjuvant RT No adjuvant RT Chi square test 
Lipofilling rate 10 (13,1%) 16 (21%) 1.2 (p<0,01) 
DIEP flap rate 15 (19,7%) 7 (9,2%) 2.5 (p<0,01) 
Infection rate 1 (1.3%) 1 (1.3%) 0 
 
 
Conclusion: In this preliminary analysis RT after mastectomy 
with breast reconstruction resulted well tolerated and can 
ensure to high risk patients local control rates comparable to 
low-medium risk patients in the early FUP. A longer period of 
observation and specific Quality of Life questionnaires are 
needed to better describe the results 
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Purpose or Objective: Whole breast clinical target volume 
(CTV) contouring rules have been defined for supine set-up. 
The same indications do not seem to fit properly for prone 
set-up and no clear definition could be found nowadays in 
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literature. This study was planned first to evaluate definition 
of prone CTV (pCTV) based on breast glandular tissue (BGT) 
distribution on diagnostic MRI, and then to analyse MRI/CT 
image fusion for treatment planning. 
 
Material and Methods: We first analyzed BGT distribution in 
30 diagnostic MRI in respect to the following structures: 
major and minor pectoralis muscles, caudal edge of 
clavicular head, sternum, skin, medial and lateral thoracic 
arteries and infra-mammary fold. Reference structures were 
derived from the latest ESTRO contouring guidelines for 
supine irradiation.The anatomical region including BGT in all 
cases was defined as pCTV. After that MRI and CT were 
acquired for treatment planning in 10 patients, planned for 
prone irradiation. Eight channel contrast-enhanced MRI was 
acquired. Axial T2 IDEAL sequences were used for pCTV 
definition. CT for treatment plan was acquired with 3 mm 
thickness and step, with dedicated prone breast board (New 
Horizon Breastboard - CIVCO Medical Solutions). pCTV was 
defined on MRI according to the above described references 
and transferred to CT with a dedicated deformable fusion 
workflow (MIM 6.4.9 - MIM Software Inc.).  
 
Results: Mean age of patients was 46 year. The well-known 
distinction in BGT distribution pattern (intermingled and 
centralized) was confirmed. pCTV could be defined superiorly 
by the caudal edge of clavicular head, inferiorly 3 mm above 
infra-mammary fold, medially by the medial thoracic artery 
(or if not visible 3 mm laterally to the sternal margin) 
laterally by a plane passing through the lateral surface of the 
pectoralis muscles and perpendicular to the skin, posteriorly 
by the anterior surface of pectoralis muscles and anteriorly 3 
mm from skin. Image fusion performed easily and transferred 
pCTV was consistent with anatomy on CT slices. Visualization 
of BGT on MRI images allowed more precise definition of 
volumes and the limits chosen for pCTV definition on MRI fit 
adequately on CT. 
 
Conclusion: Although derived from a small sample, the above 
reported contouring suggestions could be of aid in defining 
pCTV; we confirm the superiority for BGT visualization on 
MRI, The good consistency between MRI and CT anatomy 
seems to suggest that MRI criteria could be transferred on CT 
in everyday workflow for pCTV definition 
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Purpose or Objective: In the intraoperative electron 
radiotherapy (IOERT), as a part of breast-conserving therapy, 
a single high dose is applied on the tumor bed in order to 
eradicate the residual tumor cells. Currently, dose profiles 
obtained by radiochromic films are used to estimate the 
applied energy. The energy is selected by measuring the 
distance to the rib as dose limiting organ at risk by 
intraoperative ultrasound. This method is fast and practical 
for clinical applications but it is not possible to estimate the 
absorbed dose on critical organs like heart and lung. 
Therefore, an IOERT planning system was tested in order to 
evaluate the adsorbed dosage for organs at risk.  
 
Material and Methods: The dedicated mobile IOERT 
accelerator, NOVAC7 (SIT, Vicenza/Italy) was used for 
electron beam generation. The dose calculation was 
performed in Radiance (GMV, Madrid/ Spain) IOERT 
treatment planning software. Before dose calculation, the 
Radiance system was configured based on the measured data 
obtained from the electron beams. Dose calculation was 
performed based on the CT images registered a few days 
after IOERT irradiation (post-operative CT image). The 
absorbed dose in lung, heart and ribs were shown by DVHs 
and documented quantitatively. From a database of 
irradiated 53 patients n=6 patients were selected who 
developed fibrosis grade 2, edema grade 2, pneumonitis and 
suspicious heart effect (not confirmed).All of the patients 
received whole breast irradiation with 50,4 Gy/1,8 Gy SD. 
Dose constrains of the dose plans showed no exceeding the 
threshold doses. 
 
Results: Calculated dose resulted for ribs, heart and lung are 
presented in table 1. As it is shown, the absorbed dose at the 
ribs varied from 3.8 Gy to 9.2 Gy. This is partially higher than 
our tolerance dose of 7 Gy. The calculated dose values of 
different organs depend on the applied energy, the location 
of the tumor bed, the number of ribs located in the 
treatment field and the distance of the organ from the tumor 
bed. The overdoses resulted for ribs imply that the 
evaluation method of absorbed dose to rib in clinical practice 
should be optimized. On the other hand, these overdoses 
could be due to the uncertainty arising from the planning 
procedure. Because in this investigation a so-called off-line 
planning through a post-operative image was performed. This 
makes the actual applicator position and tumor bed 
localization in relation to the patient’s anatomy during the 
planning procedure difficult. 
 
 
Conclusion: No direct relation was observed between the 
side effects and the absorbed dose on heart and lung. 
Intraoperative imaging is highly recommended in order to 
increase the accuracy of the planning procedure and 
consequently the estimation of the calculated absorbed dose 
in patient. 
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Purpose or Objective: To examine locoregional and distant 
recurrence rate (LLR and DR) in breast cancer patients 
treated with breast conserving surgery and adjuvant 
radiotherapy on whole breast and nodal areas according to 
histological subtype and prognostic characteristics.  
 
Material and Methods: Between 2004 and 2013, 500 breast 
cancer patients (pts) were reviewed for this analysis. All pts 
received breast conserving surgery and adjuvant radiotherapy 
extended to nodal area because of pN+: 210 pts with pT1-2 
